Pharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FEROX STRATEGIES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | FEROX STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | FEROX STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | FEROX STRATEGIES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | FEROX STRATEGIES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | FEROX STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2024 | FEROX STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2024 | FEROX STRATEGIES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | FEROX STRATEGIES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2023 | FEROX STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FEROX STRATEGIES | 36 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 25 |
| Trade (domestic/foreign) | 12 |
| Copyright/Patent/Trademark | 11 |
| Health Issues | 8 |
| Foreign Relations | 3 |